Private Wealth Management Group’s Pacira BioSciences PCRX Stock Holding History

Private Wealth Management Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08K	Hold	82	–	–	﹤0.01%	1154
2026 Q1	$1.85K	Hold	82	–	–	﹤0.01%	1104
2025 Q4	$2.12K	Hold	82	–	–	﹤0.01%	1063
2025 Q3	$2.11K	Hold	82	–	–	﹤0.01%	1099
2025 Q2	$1.96K	Hold	82	–	–	﹤0.01%	1087
2025 Q1	$2.04K	Hold	82	–	–	﹤0.01%	1046
2024 Q4	$1.54K	Buy	82 +59	+257%	+$1.04K	﹤0.01%	1186
2024 Q3	$347	Sell	23 -117	-84%	-$2K	﹤0.01%	1452
2024 Q2	$4.01K	Buy	140 +123	+724%	+$3.5K	﹤0.01%	791
2024 Q1	$497	Buy	+17	New	+$522	﹤0.01%	1447

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Management Group's PCRX Position: Q2 2026 in Review

Private Wealth Management Group held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 82 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

Private Wealth Management Group first reported a position in PCRX in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.01K in Q2 2024. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Private Wealth Management Group held 82 shares of Pacira BioSciences worth $2.08K as of Q2 2026.
Private Wealth Management Group left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1154 holding.
Private Wealth Management Group first reported a position in Pacira BioSciences in Q1 2024 and has held it in 10 quarters since.
Private Wealth Management Group's Pacira BioSciences position peaked at $4.01K in Q2 2024.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.